Research Paper Volume 16, Issue 1 pp 267—284
A novel disulfidptosis-related lncRNAs signature for predicting survival and immune response in hepatocellular carcinoma
Figure 3. Predictive performance of the DRLs signature and establishment of clinicopathologic nomogram. ROC curves of the DRLs signature for predicting 1-, 3-, and 5-year OS in the training (A), testing (B), and TCGA cohorts (C). (D) ROC curves of the DRLs risk signature and clinical parameters for predicting 3-year OS in the TCGA cohort. (E) C-index of the DRLs signature and clinical parameters in the TCGA cohort. Univariate (F) and Multivariate (G) Cox regression analyses of the DRLs signature and clinical parameters. (H) Development of a prognostic nomogram for predicting patient survival in HCC. (I) Calibration curve of the prognostic nomogram. Abbreviations: DRLs: disulfidptosis-related lncRNAs; OS: overall survival; C-index: concordance index.